Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with ...
MRO Corp. (MRO), the leader in clinical data exchange, announces a transformative extension of its interoperability solutions ...
While poppers have previously been incorrectly linked to AIDS in the LGBTQ+ community — an unfounded stance Robert F. Kennedy ...
Oncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunotherapy platform technologies, today ...
Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience PHILADELPHIA, March 10, 2025 /PRNewswire/ ...
Skyhawk presents today on its novel SKY-0515 small molecule RNA splicing modulator targeting Huntington's Disease to members of the Huntington's Disease Youth Organization, at the annual HYDO ...
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today ...
3d
The Stand Up for Science rally in Seattle, part of a nationwide effort, filled the mural amphitheater at the Seattle Center. ...
MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX , Telix, the Company) ...
Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...
Anika announced fourth quarter revenue from continuing operations of $30.6 million increasing 1% compared to the same period ...
The Trump administration is considering changes to the national suicide hotline’s specialized service for LGBTQ-identifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback